BILLINGS CLINIC
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.7M
- Transactions
- 1,100
- Companies
- 40
- Average per transaction
- $4,295
Who reported the payments
| Eli Lilly | $871,952 |
| Abbott | $739,244 |
| Vertex | $637,609 |
| Novartis | $612,378 |
| Pfizer | $258,801 |
| AbbVie | $238,143 |
| Boston Scientific | $161,851 |
| Mallinckrodt Hospital Products Inc. | $158,353 |
| Amicus Therapeutics, Inc. | $128,095 |
| Merck | $101,072 |
| Genentech, Inc. | $76,728 |
| Insulet Corporation | $73,775 |
| Sanofi US Services Inc. | $72,612 |
| F. Hoffmann-la Roche AG | $67,251 |
| Roche Products Limited | $64,021 |
| Olympus America Inc. | $59,148 |
| E.r. Squibb & Sons, L.L.C. | $41,981 |
| Tandem Diabetes Care, Inc. | $38,450 |
| AstraZeneca | $35,627 |
| Tesaro, Inc. | $32,262 |
| Incyte Corporation | $24,511 |
| Zimmer Biomet | $16,117 |
| Med-el Corporation | $15,900 |
| Biogen | $15,215 |
| Genentech USA, Inc. | $14,750 |
| Sanofi | $14,050 |
| Lilly USA, LLC | $13,750 |
| Boehringer Ingelheim | $11,750 |
| Johnson & Johnson | $9,466 |
| Kyowa Kirin, Inc. | $8,025 |
| Regeneron Healthcare Solutions, Inc. | $8,000 |
| Organogenesis Inc. | $7,900 |
| Sterilmed, Inc. | $6,591 |
| Pinnacle Biologics, Inc | $6,050 |
| UCB, Inc. | $6,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | $5,800 |
| Bayer | $5,750 |
| Novo Nordisk | $5,500 |
| Edwards Lifesciences | $5,500 |
| Astrazeneca UK Limited | $4,850 |